Medscape |
FDA Okays Breo Ellipta for Asthma in Adults
Medscape The US Food and Drug Administration (FDA) has approved the combination of fluticasone furoate/vilanterol (Breo Ellipta, GlaxoSmithKline/Theravance) for the once-daily treatment of asthma in adults aged 18 years and older. Fluticasone furoate (FF) is an … FDA approves Glaxo, Theravance's Breo Ellipta asthma drug Glaxo Wins U.S. Approval to Sell Breo Only to Adults With Asthma FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US |
View full post on asthma – Google News